1257542-65-6

Basic information

• Product Name: (5-((5-p-tolyl-1,3,4-oxadiazol-2-yl)methylthio)-4-(2-chlorophenyl)-4H-1,2,4-triazol-3-yl)benzene-1,3-diol
• Synonyms: (5-((5-p-tolyl-1,3,4-oxadiazol-2-yl)methylthio)-4-(2-chlorophenyl)-4H-1,2,4-triazol-3-yl)benzene-1,3-diol
• CAS NO: 1257542-65-6
• Molecular Weight: 491.958
• Mol File: 1257542-65-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (5-((5-p-tolyl-1,3,4-oxadiazol-2-yl)methylthio)-4-(2-chlorophenyl)-4H-1,2,4-triazol-3-yl)benzene-1,3-diol(CAS DataBase Reference)
• NIST Chemistry Reference: (5-((5-p-tolyl-1,3,4-oxadiazol-2-yl)methylthio)-4-(2-chlorophenyl)-4H-1,2,4-triazol-3-yl)benzene-1,3-diol(1257542-65-6)
• EPA Substance Registry System: (5-((5-p-tolyl-1,3,4-oxadiazol-2-yl)methylthio)-4-(2-chlorophenyl)-4H-1,2,4-triazol-3-yl)benzene-1,3-diol(1257542-65-6)

Safety Data

• Hazardous Substances Data: 1257542-65-6(Hazardous Substances Data)

Upstream product

• 1257543-03-5 5-(4-(2-chlorophenyl)-5-mercapto-4H-1,2,4-triazol-3-yl)benzene-1,3-diol 
• 287197-95-9 2‐(chloromethyl)‐5‐(4‐methylphenyl)‐1,3,4‐oxadiazole 

Relevant articles and documents

AZOLE DERIVATIVES AS WTN PATHWAY INHIBITORS

The present invention relates to new compounds of formula I, to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy. Such compounds find particular use in the treatment and/or prevention of conditions or diseases which are affected by over-activation of signaling in the Wnt pathway. For example, these may be used in preventing and/or retarding proliferation of tumor cells, for example carcinomas such as colon carcinomas.